Curran Terrie
SEC insider (Form 3/4/5 filer). CIK 0001690298. Director at Arcutis Biotherapeutics, Inc. (ARQT) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 27, 2026. Located in WESTLAKE VILLAGE, CA.
Companies Curran Terrie has filed insider reports for
- Arcutis Biotherapeutics, Inc. (ARQT): Director
- Phathom Pharmaceuticals, Inc. (PHAT): Director, Officer, President and Chief Executive
Curran Terrie
CIK: 0001690298
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 27, 2026ARQT
Arcutis Biotherapeutics, Inc.
ExerciseDirect11.1K shares at avg. $7.51$84K - Aug 27, 2026ARQT
Arcutis Biotherapeutics, Inc.
SaleDirect11.1K shares at avg. $25.03$279K - Aug 27, 2026ARQT
Arcutis Biotherapeutics, Inc.
ExerciseDirect27.1K shares at avg. $8.63$233K - Aug 27, 2026ARQT
Arcutis Biotherapeutics, Inc.
SaleDirect27.1K shares at avg. $25.03$677K - Aug 20, 2026ARQT
Arcutis Biotherapeutics, Inc.
SaleDirect1.1K shares at avg. $26.04$28K - Aug 20, 2026ARQT
Arcutis Biotherapeutics, Inc.
ExerciseDirect1.1K shares at avg. $7.51$8K - Jun 5, 2026ARQT
Arcutis Biotherapeutics, Inc.
AwardDirect5.8K shares- - Jun 12, 2025ARQT
Arcutis Biotherapeutics, Inc.
AwardDirect7.6K shares- - Feb 27, 2025PHAT
Phathom Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
342.5K shares- - Jan 21, 2025PHAT
Phathom Pharmaceuticals, Inc.
SaleDirect19.1K shares at avg. $6.59$126K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 27, 2026 |  ARQT Arcutis Biotherapeutics, Inc. | Exercise | 11,148 | $7.51 | $83,721 | Direct |
| Aug 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale | 11,148 | $25.03 | $279,028 | Direct |
| Aug 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise | 27,052 | $8.63 | $233,459 | Direct |
| Aug 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale | 27,052 | $25.03 | $677,095 | Direct |
| Aug 20, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,072 | $26.04 | $27,912 | Direct |
| Aug 20, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise | 1,072 | $7.51 | $8,051 | Direct |
| Jun 5, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Award | 5,778 | - | $0 | Direct |
| Jun 12, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Award | 7,609 | - | - | Direct |
| Feb 27, 2025 |  PHAT Phathom Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 342,500 | - | - | Direct |
| Jan 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Sale | 19,109 | $6.59 | $125,884 | Direct |
1-10 of 11 transactions